These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 33856474)

  • 1. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
    Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
    JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Postpartum Opioid Prescriptions Before vs During the COVID-19 Pandemic.
    Steuart SR; Lawler EC; Bagwell Adams G; Shone H; Abraham AJ
    JAMA Netw Open; 2023 Apr; 6(4):e236438. PubMed ID: 37010867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of Nonpharmacologic Therapy With Opioid Prescribing for Pain During the COVID-19 Pandemic.
    Lee B; Yang KC; Kaminski P; Peng S; Odabas M; Gupta S; Green HD; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Dec; 4(12):e2138453. PubMed ID: 34889946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery.
    Sutherland TN; Wunsch H; Pinto R; Newcomb C; Brensinger C; Gaskins L; Bateman BT; Neuman MD
    JAMA Netw Open; 2021 Jun; 4(6):e2111826. PubMed ID: 34115128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022.
    Chai G; Xu J; Goyal S; Woods C; Ho A; Song J; Dal Pan G
    JAMA Psychiatry; 2024 Apr; 81(4):396-405. PubMed ID: 38198145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.
    Lei F; Lofwall MR; Freeman PR; Slade E; Vickers-Smith R; Slavova S
    J Rural Health; 2023 Jan; 39(1):186-196. PubMed ID: 35610181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016-2021.
    Larochelle MR; Jones CM; Zhang K
    Drug Alcohol Depend; 2023 Jul; 248():109933. PubMed ID: 37267746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017.
    Mikosz CA; Zhang K; Haegerich T; Xu L; Losby JL; Greenspan A; Baldwin G; Dowell D
    JAMA Netw Open; 2020 May; 3(5):e204514. PubMed ID: 32391892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
    Jones CM; Diallo MM; Vythilingam M; Schier JG; Eisenstat M; Compton WM
    Drug Alcohol Depend; 2021 Aug; 225():108783. PubMed ID: 34049102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of the New York State COVID-19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder.
    Suri A; Feaster DJ; Balise RR; Quinn J; Nunes EV; Gilbert L; El-Bassel N; Rundle AG
    Addiction; 2023 Apr; 118(4):711-718. PubMed ID: 36398540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system.
    Pergolizzi JV; Ben-Joseph R; Chang CL; Hess G
    Curr Med Res Opin; 2014 Aug; 30(8):1579-87. PubMed ID: 24689806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid prescribing in the Netherlands during the COVID-19 pandemic: a national register-based study.
    Ellerbroek H; Schellekens AFA; Kalkman GA; Visser DA; Kramers C; Dahan A; van den Heuvel SAS; Bouvy ML; van Dorp ELA
    BMJ Open; 2024 Aug; 14(8):e082369. PubMed ID: 39097314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic.
    Tanz LJ; Jones CM; Davis NL; Compton WM; Baldwin GT; Han B; Volkow ND
    JAMA Netw Open; 2023 Jan; 6(1):e2251856. PubMed ID: 36662523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
    Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
    Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends in buprenorphine prescribing before and during the COVID-19 pandemic.
    Ali MM; Creedon TB; Jacobus-Kantor L; Sherry TB
    J Subst Abuse Treat; 2023 Jan; 144():108923. PubMed ID: 36334383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in trends and pattern of strong opioid prescribing in primary care.
    Zin CS; Chen LC; Knaggs RD
    Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.